[Immunotherapy of glomerulonephritis].
Kurashige
T
T
Wakiguchi
H
H
D005921:Glomerulonephritis / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007370:Interferon Type I / Q000627:therapeutic use; D010951:Plasma Exchange; D011509:Proteoglycans / Q000627:therapeutic use; D005719:gamma-Globulins / Q000008:administration & dosage; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D007370:Interferon Type I; D011509:Proteoglycans; D005719:gamma-Globulins; D062367:ortho-Aminobenzoates; C010770:polysaccharide-K; C012293:tranilast